SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biogen Reports Diranersen Slowed Clinical Decline on Five of Six Measures at Two Years

The 60 mg dose group showed greater slowing across five of six measures at two years compared with 18 months.

BIIB

Related stories